Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation

Francesca Esposito, Cristina Tintori, Riccardo Martini, Frauke Christ, Zeger Debyser, Roberto Ferrarese, Gianluigi Cabiddu, Angela Corona, Elisa Rita Ceresola, Andrea Calcaterra, Valentina Iovine, Bruno Botta, Massimo Clementi, Filippo Canducci, Maurizio Botta, Enzo Tramontano

Research output: Contribution to journalArticle

Abstract

HIV-1 integrase (IN) active site inhibitors are the latest class of drugs approved for HIV treatment. The selection of IN strand-transfer drug-resistant HIV strains in patients supports the development of new agents that are active as allosteric IN inhibitors. Here, a docking-based virtual screening has been applied to a small library of natural ligands to identify new allosteric IN inhibitors that target the sucrose binding pocket. From theoretical studies, kuwanon-L emerged as the most promising binder and was thus selected for biological studies. Biochemical studies showed that kuwanon-L is able to inhibit the HIV-1 IN catalytic activity in the absence and in the presence of LEDGF/p75 protein, the IN dimerization, and the IN/LEDGF binding. Kuwanon-L also inhibited HIV-1 replication in cell cultures. Overall, docking and biochemical results suggest that kuwanon-L binds to an allosteric binding pocket and can be considered an attractive lead for the development of new allosteric IN antiviral agents. Docking simulations exploring a small library of natural compounds, together with biological studies, allowed kuwanon-L to be identified as a new HIV-1 integrase (IN) inhibitor with an allosteric mode of action. Kuwanon-L can thus be considered an attractive lead for the development of new allosteric IN antiviral agents.

Original languageEnglish
Pages (from-to)2507-2512
Number of pages6
JournalChemBioChem
Volume16
Issue number17
DOIs
Publication statusPublished - Nov 23 2015

Fingerprint

HIV Integrase Inhibitors
Integrase Inhibitors
Integrases
Molecular modeling
Antiviral Agents
Protein Multimerization
HIV
Dimerization
Cell culture
Pharmaceutical Preparations
Binders
Sucrose
Catalyst activity
Screening
p31 integrase protein, Human immunodeficiency virus 1
kuwanon-L
HIV-1
Catalytic Domain
Ligands
Theoretical Models

Keywords

  • allosterism
  • HIV-1 integrase
  • inhibitors
  • integrase multimerization
  • kuwanon-L
  • protein-protein interactions

ASJC Scopus subject areas

  • Biochemistry
  • Organic Chemistry
  • Molecular Medicine
  • Molecular Biology

Cite this

Esposito, F., Tintori, C., Martini, R., Christ, F., Debyser, Z., Ferrarese, R., ... Tramontano, E. (2015). Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation. ChemBioChem, 16(17), 2507-2512. https://doi.org/10.1002/cbic.201500385

Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor : Molecular Modeling and Biological Evaluation. / Esposito, Francesca; Tintori, Cristina; Martini, Riccardo; Christ, Frauke; Debyser, Zeger; Ferrarese, Roberto; Cabiddu, Gianluigi; Corona, Angela; Ceresola, Elisa Rita; Calcaterra, Andrea; Iovine, Valentina; Botta, Bruno; Clementi, Massimo; Canducci, Filippo; Botta, Maurizio; Tramontano, Enzo.

In: ChemBioChem, Vol. 16, No. 17, 23.11.2015, p. 2507-2512.

Research output: Contribution to journalArticle

Esposito, F, Tintori, C, Martini, R, Christ, F, Debyser, Z, Ferrarese, R, Cabiddu, G, Corona, A, Ceresola, ER, Calcaterra, A, Iovine, V, Botta, B, Clementi, M, Canducci, F, Botta, M & Tramontano, E 2015, 'Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation', ChemBioChem, vol. 16, no. 17, pp. 2507-2512. https://doi.org/10.1002/cbic.201500385
Esposito F, Tintori C, Martini R, Christ F, Debyser Z, Ferrarese R et al. Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation. ChemBioChem. 2015 Nov 23;16(17):2507-2512. https://doi.org/10.1002/cbic.201500385
Esposito, Francesca ; Tintori, Cristina ; Martini, Riccardo ; Christ, Frauke ; Debyser, Zeger ; Ferrarese, Roberto ; Cabiddu, Gianluigi ; Corona, Angela ; Ceresola, Elisa Rita ; Calcaterra, Andrea ; Iovine, Valentina ; Botta, Bruno ; Clementi, Massimo ; Canducci, Filippo ; Botta, Maurizio ; Tramontano, Enzo. / Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor : Molecular Modeling and Biological Evaluation. In: ChemBioChem. 2015 ; Vol. 16, No. 17. pp. 2507-2512.
@article{104047a204ce4d62bf4e78ffa2593de6,
title = "Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor: Molecular Modeling and Biological Evaluation",
abstract = "HIV-1 integrase (IN) active site inhibitors are the latest class of drugs approved for HIV treatment. The selection of IN strand-transfer drug-resistant HIV strains in patients supports the development of new agents that are active as allosteric IN inhibitors. Here, a docking-based virtual screening has been applied to a small library of natural ligands to identify new allosteric IN inhibitors that target the sucrose binding pocket. From theoretical studies, kuwanon-L emerged as the most promising binder and was thus selected for biological studies. Biochemical studies showed that kuwanon-L is able to inhibit the HIV-1 IN catalytic activity in the absence and in the presence of LEDGF/p75 protein, the IN dimerization, and the IN/LEDGF binding. Kuwanon-L also inhibited HIV-1 replication in cell cultures. Overall, docking and biochemical results suggest that kuwanon-L binds to an allosteric binding pocket and can be considered an attractive lead for the development of new allosteric IN antiviral agents. Docking simulations exploring a small library of natural compounds, together with biological studies, allowed kuwanon-L to be identified as a new HIV-1 integrase (IN) inhibitor with an allosteric mode of action. Kuwanon-L can thus be considered an attractive lead for the development of new allosteric IN antiviral agents.",
keywords = "allosterism, HIV-1 integrase, inhibitors, integrase multimerization, kuwanon-L, protein-protein interactions",
author = "Francesca Esposito and Cristina Tintori and Riccardo Martini and Frauke Christ and Zeger Debyser and Roberto Ferrarese and Gianluigi Cabiddu and Angela Corona and Ceresola, {Elisa Rita} and Andrea Calcaterra and Valentina Iovine and Bruno Botta and Massimo Clementi and Filippo Canducci and Maurizio Botta and Enzo Tramontano",
year = "2015",
month = "11",
day = "23",
doi = "10.1002/cbic.201500385",
language = "English",
volume = "16",
pages = "2507--2512",
journal = "ChemBioChem",
issn = "1439-4227",
publisher = "Wiley-VCH Verlag",
number = "17",

}

TY - JOUR

T1 - Kuwanon-L as a New Allosteric HIV-1 Integrase Inhibitor

T2 - Molecular Modeling and Biological Evaluation

AU - Esposito, Francesca

AU - Tintori, Cristina

AU - Martini, Riccardo

AU - Christ, Frauke

AU - Debyser, Zeger

AU - Ferrarese, Roberto

AU - Cabiddu, Gianluigi

AU - Corona, Angela

AU - Ceresola, Elisa Rita

AU - Calcaterra, Andrea

AU - Iovine, Valentina

AU - Botta, Bruno

AU - Clementi, Massimo

AU - Canducci, Filippo

AU - Botta, Maurizio

AU - Tramontano, Enzo

PY - 2015/11/23

Y1 - 2015/11/23

N2 - HIV-1 integrase (IN) active site inhibitors are the latest class of drugs approved for HIV treatment. The selection of IN strand-transfer drug-resistant HIV strains in patients supports the development of new agents that are active as allosteric IN inhibitors. Here, a docking-based virtual screening has been applied to a small library of natural ligands to identify new allosteric IN inhibitors that target the sucrose binding pocket. From theoretical studies, kuwanon-L emerged as the most promising binder and was thus selected for biological studies. Biochemical studies showed that kuwanon-L is able to inhibit the HIV-1 IN catalytic activity in the absence and in the presence of LEDGF/p75 protein, the IN dimerization, and the IN/LEDGF binding. Kuwanon-L also inhibited HIV-1 replication in cell cultures. Overall, docking and biochemical results suggest that kuwanon-L binds to an allosteric binding pocket and can be considered an attractive lead for the development of new allosteric IN antiviral agents. Docking simulations exploring a small library of natural compounds, together with biological studies, allowed kuwanon-L to be identified as a new HIV-1 integrase (IN) inhibitor with an allosteric mode of action. Kuwanon-L can thus be considered an attractive lead for the development of new allosteric IN antiviral agents.

AB - HIV-1 integrase (IN) active site inhibitors are the latest class of drugs approved for HIV treatment. The selection of IN strand-transfer drug-resistant HIV strains in patients supports the development of new agents that are active as allosteric IN inhibitors. Here, a docking-based virtual screening has been applied to a small library of natural ligands to identify new allosteric IN inhibitors that target the sucrose binding pocket. From theoretical studies, kuwanon-L emerged as the most promising binder and was thus selected for biological studies. Biochemical studies showed that kuwanon-L is able to inhibit the HIV-1 IN catalytic activity in the absence and in the presence of LEDGF/p75 protein, the IN dimerization, and the IN/LEDGF binding. Kuwanon-L also inhibited HIV-1 replication in cell cultures. Overall, docking and biochemical results suggest that kuwanon-L binds to an allosteric binding pocket and can be considered an attractive lead for the development of new allosteric IN antiviral agents. Docking simulations exploring a small library of natural compounds, together with biological studies, allowed kuwanon-L to be identified as a new HIV-1 integrase (IN) inhibitor with an allosteric mode of action. Kuwanon-L can thus be considered an attractive lead for the development of new allosteric IN antiviral agents.

KW - allosterism

KW - HIV-1 integrase

KW - inhibitors

KW - integrase multimerization

KW - kuwanon-L

KW - protein-protein interactions

UR - http://www.scopus.com/inward/record.url?scp=84954369076&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84954369076&partnerID=8YFLogxK

U2 - 10.1002/cbic.201500385

DO - 10.1002/cbic.201500385

M3 - Article

AN - SCOPUS:84954369076

VL - 16

SP - 2507

EP - 2512

JO - ChemBioChem

JF - ChemBioChem

SN - 1439-4227

IS - 17

ER -